Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Quality of Life After AVR
Author(s): Meng He , Jinwei Zhang , Jianbo Yu , et al Added: 1 month ago

Heart Failure
TAVR is Ready for Most Low-risk Patients
Author(s): Ahmad Jabri , Anas Alameh , Gennaro Giustino , et al Added: 10 months ago

Intervention

Vascular Disease and Surgery
EuroPCR 25: The TRINITY Trial
Author(s): Thomas Modine Added: 1 month ago
EuroPCR25 - Findings from TRINITY trial show favourable outcomes with the LuX-Valve Plus TTVR system in high-risk patients with severe tricuspid regurgitation.We are joined by Prof Thomas Modine (CHU de Bordeaux, Bordeaux, FR) to discuss key findings from the TRINITY trial. This prospective, single-arm, multi-center study evaluated the LuX-Valve Plus transjugular tricuspid valve replacement… View more

Heart Failure

Intervention
New York Valves 2025
Start date: Jun 25, 2025 End date: Jun 27, 2025
New York Valves 2025 summit, sponsored by the Cardiovascular Research Foundation, is set to take place from June 25th to 27th at Jacob K. Javits Convention Center in New York. The program will offer insights into the latest practises in valvular and structural heart care. View more

Heart Failure

Intervention
TCT 24: The TAVR UNLOAD Trial
Author(s): Nicolas M Van Mieghem Added: 8 months ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) in addition to optimal heart failure therapy (OHFT) compared to OHFT alone in patients with heart failure and moderate aortic stenosis.Dr Nicolas M Van Mieghem (Erasmus University Medical Center, Rotterdam, NL) joins us onsite at TCT Conference to discuss the findings from TAVR UNLOAD (NCT02661451)… View more

Heart Failure

Intervention
Job title: Research Fellow
TCT 24: The MATTERHORN Trial
Author(s): Stephan Baldus Added: 8 months ago
TCT Conference 2024 - Clinical outcomes between percutaneous mitral valve repair (PMVR) and mitral valve surgery in patients with atrial mitral regurgitation (MR).Dr Stephan Baldus (University of Köln Medical Center, DE) joins us onsite at TCT Conference to discuss the findings from MATTERHORN (NCT02371512; University of Köln).MATTERHORN is a multicenter, randomized controlled clinical trial,… View more

Heart Failure

Intervention
Nicolo Piazza
Job title: Assistant Professor to the Cardiology Division
Dr. Nicolo Piazza, Assistant Professor to the Cardiology Division and Attending at the MUHC. Dr. Piazza earned his medical degree at McGill University, where he subsequently completed post-graduate training in Cardiology. He completed a one year interventional cardiology clinical fellowship at the Montreal Heart Institute and two subsequent fellowships – a two year PhD research fellowship in… View more
Cha Rajakaruna
Job title: Consultant Cardiac Surgeon, Bristol Heart Institute, Bristol, UK
Mr. Cha Rajakaruna is a highly esteemed consultant cardiothoracic surgeon specializing in minimally invasive aortic valve replacement, coronary bypass surgery, atrial fibrillation, atrial fibrillation ablation, TAVI (transcatheter aortic valve implantation), and minimally invasive aortic valve repair. He currently practices at Spire Bristol Hospital.Mr. Rajakaruna earned his medical degree (MB… View more
Dr Gilbert Tang is Surgical Director of the Structural Heart Program at the Mount Sinai Health System and Professor of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai in New York. He has performed over 2000 cases of transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair (MitraClip), transcatheter mitral valve replacement, and tricuspid valve repair… View more